drugset / Trial / NCT01826188

Combined THC and CBD Drops for Treatment of Crohn's Disease

NCT01826188 ↗

Phase 1/2 Completed 50 enrolled Meir Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

There are many reports about efficacy of Cannabis in Crohn's disease but no controlled trials. The aim of the proposed trial is to investigate the efficacy of oil containing the cannabinoids THC and CBD given by mouth for induction of remission in Crohn's disease.

Timeline

Start
2013-03
Primary completion
2018-06
Completion
2018-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator CBD Unknown 50 mg/ml Oral
Comparator THC Unknown 5 mg/ml Oral

Indications